|
FNIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.425900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.655600E-01 |
| Normal-vs-Stage2 |
5.429500E-02 |
| Normal-vs-Stage3 |
1.227250E-01 |
| Normal-vs-Stage4 |
1.896200E-01 |
| Stage1-vs-Stage2 |
1.006790E-01 |
| Stage1-vs-Stage3 |
2.031400E-01 |
| Stage1-vs-Stage4 |
1.493780E-01 |
| Stage2-vs-Stage3 |
7.193000E-01 |
| Stage2-vs-Stage4 |
8.617600E-01 |
| Stage3-vs-Stage4 |
6.597800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.097600E-02 |
| Normal-vs-AfricanAmerican |
1.289580E-01 |
| Normal-vs-Asian |
3.699200E-01 |
| Caucasian-vs-AfricanAmerican |
6.827400E-01 |
| Caucasian-vs-Asian |
4.807600E-01 |
| AfricanAmerican-vs-Asian |
6.252200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.222200E-01 |
| Normal-vs-Female |
1.564140E-03 |
| Male-vs-Female |
1.033680E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.238210E-01 |
| Normal-vs-Extreme_Weight |
8.574600E-01 |
| Normal-vs-Obese |
3.430300E-02 |
| Normal-vs-Extreme_Obese |
8.243400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.049580E-01 |
| Normal_Weight-vs-Obese |
9.315600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.866000E-01 |
| Extreme_Weight-vs-Obese |
2.613900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.079400E-01 |
| Obese-vs-Extreme_Obese |
3.764000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.626200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.456000E-03 |
| Normal-vs-Age(61-80Yrs) |
7.366600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.213000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.483200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.431380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.080200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.100500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.252000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.908600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.945000E-01 |
| Normal-VS-Type2 PRCC |
2.921200E-03 |
| Normal-VS-KIRP CIMP |
8.750200E-01 |
| Normal-VS-Unclassified PRCC |
4.171800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.455800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.638000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.304400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.759220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.001000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.179600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.982400E-01 |
| Normal-vs-N1 |
3.672200E-02 |
| Normal-vs-N2 |
4.396800E-01 |
| N0-vs-N1 |
1.257200E-01 |
| N0-vs-N2 |
6.542600E-01 |
| N1-vs-N2 |
7.798600E-01 |
|
|
